FC could be a useful marker when novel, more specific drugs targeting the GI tract in SSc will be introduced. PubMed, Arthritis Res Ther, 2014 Feb 6. (Also see: Systemic Scleroderma Prognosis and Mortality: Biomarkers)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.